Holroyd K A, Holm J F, Penzien D B, Cordingley G E, Hursey K G, Martin N J, Theofanous A
Department of Psychology, Ohio University, Athens 45701-2979.
Biofeedback Self Regul. 1989 Dec;14(4):301-8. doi: 10.1007/BF00999121.
This report presents the first prospective comparison of the long-term maintenance of reductions in recurrent migraine headaches achieved with (abortive) pharmacological and nonpharmacological (combined relaxation training and thermal biofeedback training) treatments. Nineteen of 21 (90%) successfully treated patients (50% or greater reduction in headache activity) were contacted for follow-up evaluation 3 years later. Migraine sufferers who had been treated with ergotamine were less likely to still be relying on the treatment they had received and more likely to have additional medical treatment for their headaches and to be using prophylactic or narcotic medication than were migraine sufferers who had been treated with relaxation/biofeedback training. However, daily headache recordings revealed that patients in both treatment groups continued to show lower headache activity at 3-year follow-up than prior to treatment. Although preliminary, these findings raise the possibility that improvements achieved with nonpharmacological treatment are more likely to be maintained without additional treatment than are similar improvements achieved with abortive pharmacological treatment.
本报告首次对通过(终止性)药物治疗和非药物治疗(联合放松训练和热生物反馈训练)实现复发性偏头痛头痛减少的长期维持情况进行了前瞻性比较。21名成功治疗的患者中有19名(90%)(头痛活动减少50%或更多)在3年后接受了随访评估。与接受放松/生物反馈训练治疗的偏头痛患者相比,接受麦角胺治疗的偏头痛患者继续依赖其所接受治疗的可能性较小,更有可能因头痛接受额外的医学治疗,以及使用预防性或麻醉性药物。然而,每日头痛记录显示,两个治疗组的患者在3年随访时的头痛活动仍低于治疗前。尽管这些发现是初步的,但它们提出了一种可能性,即与通过终止性药物治疗取得的类似改善相比,非药物治疗取得的改善更有可能在不进行额外治疗的情况下得以维持。